3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
Conditions
Neoplasms
5
Ovarian Neoplasms
3
Lung Neoplasms
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Lymphoma
2
Head and Neck Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Brain Neoplasms
2
Adenocarcinoma
2
Urticaria
1
Tuberous Sclerosis
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Severe Combined Immunodeficiency
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Rectal Neoplasms
1
Pancreatitis, Chronic
1
Pancreatitis
1
Pancreatic Cyst
1
Non-alcoholic Fatty Liver Disease
1
Neuroendocrine Tumors
1
Neuroblastoma
1
Nephritis
1
Neoplasm Metastasis
1
Multiple Sclerosis
1
Mucopolysaccharidosis I
1
Melanoma
1
Interventions
Gene Expression Profiling
9
Blood Specimen Collection
6
Polymerase Chain Reaction
5
Immunohistochemistry
5
Amplified Fragment Length Polymorphism Analysis
5
Surveys and Questionnaires
3
Sunitinib
3
Reverse Transcriptase Polymerase Chain Reaction
3
Flow Cytometry
3
Biopsy
3
Surgical Procedures, Operative
2
Radiotherapy
2
Radiosurgery
2
Patient Reported Outcome Measures
2
Observation
2
Nivolumab
2
Microarray Analysis
2
Immunotherapy
2
Genetic Testing
2
Drug Therapy
2
DNA Methylation
2
Cytogenetic Analysis
2
tremelimumab
1
pembrolizumab
1
durvalumab
1
atezolizumab
1
aldesleukin
1
X-Rays
1
Watchful Waiting
1
Tomography, Optical Coherence
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Kidney Neoplasms
×
Phlebotomy
×
Clear all
NCT04154163
2022-02-28
ADOPT
University of Dundee
Completed
18 enrolled